| Q35574894 | A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation. |
| Q44356488 | A reporter gene assay for evaluation of tissue-specific responses to estrogens based on the differential use of promoters A to F of the human estrogen receptor alpha gene |
| Q61798901 | Aberrant DNA methylation suppresses expression of estrogen receptor 1 (ESR1) in ovarian endometrioma |
| Q33690360 | Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer |
| Q36633134 | Aging of brain: role of estrogen. |
| Q34340354 | Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity. |
| Q34002291 | Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture |
| Q33837034 | CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome |
| Q36544709 | Chaperone gp96 mediates ER-α36 cell membrane expression |
| Q26751646 | Colorectal cancers and chlorinated water |
| Q33560278 | Coordinated regulation of nuclear receptor CAR by CCRP/DNAJC7, HSP70 and the ubiquitin-proteasome system |
| Q38356127 | Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling |
| Q35009790 | DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations |
| Q36210983 | ERα phosphorylation at Y537 by Src triggers E6-AP-ERα binding, ERα ubiquitylation, promoter occupancy, and target gene expression. |
| Q37182447 | Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages |
| Q42165712 | Estrogen receptor genotype modulates myocardial perfusion in young men. |
| Q36756461 | Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome |
| Q43204321 | Estrogen stimulates female biliary epithelial cell interleukin-6 expression in mice and humans |
| Q24607057 | FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis |
| Q37301981 | Fli1 is a negative regulator of estrogen receptor α in dermal fibroblasts |
| Q44548365 | Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy |
| Q37188580 | Human pancreas-specific protein disulfide isomerase homolog (PDIp) is an intracellular estrogen-binding protein that modulates estrogen levels and actions in target cells |
| Q33632085 | In search of novel drug target sites on estrogen receptors using RNA aptamers |
| Q36851417 | Mechanisms of Endocrine Resistance in Breast Cancer |
| Q37288111 | Membrane estradiol signaling in the brain |
| Q34181207 | Molecular and cellular determinants of estrogen receptor alpha expression |
| Q47140933 | Molecular mechanism of estrogen-estrogen receptor signaling |
| Q36159454 | Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli |
| Q38063566 | Mutations and polymorphisms of estrogens receptors genes and diseases susceptibility |
| Q35622050 | New insights into estrogen receptor function in human breast cancer |
| Q48723616 | Novel Splicing Events of Untranslated First Exons in Human Estrogen Receptor Alpha(ER.ALPHA.) Gene |
| Q28263821 | Phosphorylation of the histone deacetylase 7 modulates its stability and association with 14-3-3 proteins |
| Q37034028 | Phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study. |
| Q35842790 | Post-translational modifications of nuclear receptors and human disease |
| Q28651483 | Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines |
| Q37334047 | Repression of ESR1 through actions of estrogen receptor alpha and Sin3A at the proximal promoter |
| Q36800212 | Reversibility of aberrant global DNA and estrogen receptor-alpha gene methylation distinguishes colorectal precancer from cancer. |
| Q36164767 | Role of histone acetylation in the control of gene expression |
| Q46727875 | Role of inflammatory cytokines in the effect of estradiol on atheroma. |
| Q36044425 | Single-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study |
| Q34334394 | The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis |
| Q36735733 | The Predominant Proteins that React to the MC-20 Estrogen Receptor Alpha Antibody Differ in Molecular Weight between the Mammary Gland and Uterus in the Mouse and Rat. |
| Q24301763 | The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription |
| Q40114061 | The clock gene Per2 links the circadian system to the estrogen receptor |
| Q40624316 | The co-repressor hairless protects RORalpha orphan nuclear receptor from proteasome-mediated degradation |
| Q36482278 | The estrogen effects on endothelial repair and mitogen-activated protein kinase activation are abolished in endothelial nitric-oxide (NO) synthase knockout mice, but not by NO synthase inhibition by N-nitro-L-arginine methyl ester |
| Q44510505 | The novel 5'-untranslated first exon, exon 0H, of the rat estrogen receptor beta gene |
| Q27008878 | The role of estrogen and androgen receptors in bone health and disease |
| Q33631415 | Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR. |
| Q36655236 | Understanding the oestrogen action in experimental and clinical atherosclerosis. |
| Q34117084 | Variation among rainbow trout (Oncorhynchus mykiss) estrogen receptor isoform 3' untranslated regions and the effect of 17beta-estradiol on mRNA stability in hepatocyte culture |
| Q91846499 | ZBTB7A governs estrogen receptor alpha expression in breast cancer |
| Q28504741 | c-Src-null mice exhibit defects in normal mammary gland development and ERalpha signaling |
| Q24644154 | miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA |